The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy  Olaf A. Brinkmann, Michael Semik, Georg Gosherger, Lothar Hertle  European Urology Supplements  Volume 6, Issue 10, Pages 641-645 (May 2007) DOI: 10.1016/j.eursup.2007.03.003 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier survival curves of the study groups treated with immunotherapy (IMT) alone (group A) and with IMT in combination with the excision of residual metastatic lesions (group B). European Urology Supplements 2007 6, 641-645DOI: (10.1016/j.eursup.2007.03.003) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 A 62-year-old male with metastatic renal cell carcinoma (mRCC, pT3apN0pM1/G3) and bilateral renal tumors showing a lung metastasis prior to treatment (A) and complete remission after treatment (B). Liver metastasis is shown prior to treatment (C) and after treatment with complete resolution (D). Left lower pole kidney tumor prior to treatment (E) and with partial remission after treatment (F). This lesion was finally resected with organ preservation of the kidney. European Urology Supplements 2007 6, 641-645DOI: (10.1016/j.eursup.2007.03.003) Copyright © 2007 European Association of Urology Terms and Conditions